AVXL Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued RD Focus Precision BioSciences DTIL Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Unreported Stock Edges Higher Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses YJ Q3 2024 Earnings Significant EPS Miss Triggers Stock Decline Lunai Bioworks Inc LNAI Q1 2026 Earnings PreRevenue Biotech Reports WiderThanExpected Loss Amid Pipeline Progress CNTN Q4 2023 Earnings Significant Loss Beat as Strategic Initiatives Gain Traction